{"transactions":[{"id":768645,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-05-21T20:05:47.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":27440,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the restricted stock units granted on May 20, 2026 was as follows: 9,147 shares will vest on February 26, 2027; 9,147 shares will vest on February 26, 2028; and 9,146 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"date","element":"transactionDate","label":"F6","text":"The restricted stock units were approved by Inovio's Board of Directors on March 4, 2026, subject to shareholder approval of the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan under which the restricted stock units were granted. Inovio's shareholders approved the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan on May 20, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the restricted stock units granted on May 20, 2026 was as follows: 9,147 shares will vest on February 26, 2027; 9,147 shares will vest on February 26, 2028; and 9,146 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the restricted stock units granted on May 20, 2026 was as follows: 9,147 shares will vest on February 26, 2027; 9,147 shares will vest on February 26, 2028; and 9,146 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":27440,"derivative":{"underlying":"Common Stock","underlying_shares":27440},"source":{"system":"sec-edgar","filing":"0001770390-26-000005","document":"wk-form4_1779393944.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000177039026000005/wk-form4_1779393944.xml","form_type":"4"}},{"id":768644,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock Option","published_at":"2026-05-21T20:05:47.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":34160,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F3","text":"The stock option grant was approved by Inovio's Board of Directors on March 4, 2026, subject to shareholder approval of the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan under which the stock options were granted. Inovio's shareholders approved the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan on May 20, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The vesting schedule for the options granted on May 20, 2026 was as follows: 11,387 shares will vest on February 26, 2027; 11,387 shares will vest on February 26, 2028; 11,386 shares will vest on February 26, 2029."}],"balance_after":34160,"derivative":{"exercise_price":1.73,"expiration_date":"2036-05-20","underlying":"Common Stock","underlying_shares":34160},"source":{"system":"sec-edgar","filing":"0001770390-26-000005","document":"wk-form4_1779393944.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000177039026000005/wk-form4_1779393944.xml","form_type":"4"}},{"id":768643,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-05-21T20:05:47.000Z","date":"2026-05-20","kind":"exercise","planned":false,"acquired":false,"shares":6027,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 18,081 restricted stock units was as follows: 6,027 shares vested on May 20, 2026; 6,027 shares will vest on May 20, 2027; 6,027 shares will vest on May 20, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 18,081 restricted stock units was as follows: 6,027 shares vested on May 20, 2026; 6,027 shares will vest on May 20, 2027; 6,027 shares will vest on May 20, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 18,081 restricted stock units was as follows: 6,027 shares vested on May 20, 2026; 6,027 shares will vest on May 20, 2027; 6,027 shares will vest on May 20, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":12054,"derivative":{"underlying":"Common Stock","underlying_shares":6027},"source":{"system":"sec-edgar","filing":"0001770390-26-000005","document":"wk-form4_1779393944.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000177039026000005/wk-form4_1779393944.xml","form_type":"4"}},{"id":768642,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-05-21T20:05:47.000Z","date":"2026-05-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":2163,"price":1.23,"value":2660.49,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein."}],"balance_after":46823,"source":{"system":"sec-edgar","filing":"0001770390-26-000005","document":"wk-form4_1779393944.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000177039026000005/wk-form4_1779393944.xml","form_type":"4"}},{"id":768641,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-05-21T20:05:47.000Z","date":"2026-05-20","kind":"exercise","planned":false,"acquired":true,"shares":6027,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 18,081 restricted stock units was as follows: 6,027 shares vested on May 20, 2026; 6,027 shares will vest on May 20, 2027; 6,027 shares will vest on May 20, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":48986,"source":{"system":"sec-edgar","filing":"0001770390-26-000005","document":"wk-form4_1779393944.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000177039026000005/wk-form4_1779393944.xml","form_type":"4"}},{"id":775624,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-05-18T20:06:42.000Z","date":"2026-05-15","kind":"exercise","planned":false,"acquired":false,"shares":4771,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 14,313 restricted stock units was as follows: 4,771 shares vested on May 15, 2024; 4,771 shares vested on May 15, 2025; and 4,771 shares vested on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 14,313 restricted stock units was as follows: 4,771 shares vested on May 15, 2024; 4,771 shares vested on May 15, 2025; and 4,771 shares vested on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 14,313 restricted stock units was as follows: 4,771 shares vested on May 15, 2024; 4,771 shares vested on May 15, 2025; and 4,771 shares vested on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4771},"source":{"system":"sec-edgar","filing":"0001770390-26-000004","document":"wk-form4_1779134799.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000177039026000004/wk-form4_1779134799.xml","form_type":"4"}},{"id":775623,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-05-18T20:06:42.000Z","date":"2026-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":1712,"price":1.3,"value":2225.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein."}],"balance_after":42959,"source":{"system":"sec-edgar","filing":"0001770390-26-000004","document":"wk-form4_1779134799.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000177039026000004/wk-form4_1779134799.xml","form_type":"4"}},{"id":775622,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-05-18T20:06:42.000Z","date":"2026-05-15","kind":"exercise","planned":false,"acquired":true,"shares":4771,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 14,313 restricted stock units was as follows: 4,771 shares vested on May 15, 2024; 4,771 shares vested on May 15, 2025; and 4,771 shares vested on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":44671,"source":{"system":"sec-edgar","filing":"0001770390-26-000004","document":"wk-form4_1779134799.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000177039026000004/wk-form4_1779134799.xml","form_type":"4"}},{"id":859349,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-03-05T21:55:40.000Z","date":"2026-03-04","kind":"grant","planned":false,"acquired":true,"shares":21560,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 21,560 restricted stock units granted on March 4, 2026 was as follows: 7,187 shares will vest on February 26, 2027; 7,187 shares will vest on February 26, 2028; and 7,186 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 21,560 restricted stock units granted on March 4, 2026 was as follows: 7,187 shares will vest on February 26, 2027; 7,187 shares will vest on February 26, 2028; and 7,186 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 21,560 restricted stock units granted on March 4, 2026 was as follows: 7,187 shares will vest on February 26, 2027; 7,187 shares will vest on February 26, 2028; and 7,186 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":21560,"derivative":{"underlying":"Common Stock","underlying_shares":21560},"source":{"system":"sec-edgar","filing":"0001770390-26-000003","document":"wk-form4_1772747737.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000177039026000003/wk-form4_1772747737.xml","form_type":"4"}},{"id":859348,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock Option","published_at":"2026-03-05T21:55:40.000Z","date":"2026-03-04","kind":"grant","planned":false,"acquired":true,"shares":26840,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The vesting schedule for the 26,840 options granted on March 4, 2026 was as follows: 8,947 shares will vest on February 26, 2027; 8,947 shares will vest on February 26, 2028; 8,946 shares will vest on February 26, 2029."}],"balance_after":26840,"derivative":{"exercise_price":1.73,"expiration_date":"2036-02-26","underlying":"Common Stock","underlying_shares":26840},"source":{"system":"sec-edgar","filing":"0001770390-26-000003","document":"wk-form4_1772747737.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000177039026000003/wk-form4_1772747737.xml","form_type":"4"}},{"id":878029,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-02-27T21:49:03.000Z","date":"2026-02-26","kind":"exercise","planned":false,"acquired":false,"shares":7366,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 22,098 restricted stock units granted on February 27, 2025 was as follows: 7,366 shares vested on February 26, 2026; 7,366 shares will vest on February 26, 2027; 7,366 shares will vest on February 26, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 22,098 restricted stock units granted on February 27, 2025 was as follows: 7,366 shares vested on February 26, 2026; 7,366 shares will vest on February 26, 2027; 7,366 shares will vest on February 26, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 22,098 restricted stock units granted on February 27, 2025 was as follows: 7,366 shares vested on February 26, 2026; 7,366 shares will vest on February 26, 2027; 7,366 shares will vest on February 26, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":14732,"derivative":{"underlying":"Common Stock","underlying_shares":7366},"source":{"system":"sec-edgar","filing":"0001770390-26-000002","document":"wk-form4_1772228940.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000177039026000002/wk-form4_1772228940.xml","form_type":"4"}},{"id":878028,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-02-27T21:49:03.000Z","date":"2026-02-26","kind":"exercise","planned":false,"acquired":false,"shares":5010,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 15,029 restricted stock units granted on February 28, 2024 was as follows: 5,010 shares vested on February 26, 2025; 5,010 shares vested on February 26, 2026; and 5,009 shares will vest on February 26, 2027.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 15,029 restricted stock units granted on February 28, 2024 was as follows: 5,010 shares vested on February 26, 2025; 5,010 shares vested on February 26, 2026; and 5,009 shares will vest on February 26, 2027.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 15,029 restricted stock units granted on February 28, 2024 was as follows: 5,010 shares vested on February 26, 2025; 5,010 shares vested on February 26, 2026; and 5,009 shares will vest on February 26, 2027.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":5009,"derivative":{"underlying":"Common Stock","underlying_shares":5010},"source":{"system":"sec-edgar","filing":"0001770390-26-000002","document":"wk-form4_1772228940.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000177039026000002/wk-form4_1772228940.xml","form_type":"4"}},{"id":878027,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-02-27T21:49:03.000Z","date":"2026-02-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":3034,"price":1.79,"value":5430.86,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (3) herein."}],"balance_after":39900,"source":{"system":"sec-edgar","filing":"0001770390-26-000002","document":"wk-form4_1772228940.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000177039026000002/wk-form4_1772228940.xml","form_type":"4"}},{"id":878026,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-02-27T21:49:03.000Z","date":"2026-02-26","kind":"exercise","planned":false,"acquired":true,"shares":7366,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 22,098 restricted stock units granted on February 27, 2025 was as follows: 7,366 shares vested on February 26, 2026; 7,366 shares will vest on February 26, 2027; 7,366 shares will vest on February 26, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":42934,"source":{"system":"sec-edgar","filing":"0001770390-26-000002","document":"wk-form4_1772228940.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000177039026000002/wk-form4_1772228940.xml","form_type":"4"}},{"id":878025,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-02-27T21:49:03.000Z","date":"2026-02-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":2064,"price":1.79,"value":3694.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein."}],"balance_after":35568,"source":{"system":"sec-edgar","filing":"0001770390-26-000002","document":"wk-form4_1772228940.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000177039026000002/wk-form4_1772228940.xml","form_type":"4"}},{"id":878024,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-02-27T21:49:03.000Z","date":"2026-02-26","kind":"exercise","planned":false,"acquired":true,"shares":5010,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 15,029 restricted stock units granted on February 28, 2024 was as follows: 5,010 shares vested on February 26, 2025; 5,010 shares vested on February 26, 2026; and 5,009 shares will vest on February 26, 2027.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":37632,"source":{"system":"sec-edgar","filing":"0001770390-26-000002","document":"wk-form4_1772228940.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000177039026000002/wk-form4_1772228940.xml","form_type":"4"}},{"id":1139374,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock Option","published_at":"2025-05-21T20:58:48.000Z","date":"2025-05-20","kind":"grant","planned":false,"acquired":true,"shares":22419,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The vesting schedule for the 22,419 options is as follows: 11,210 shares will vest on May 20, 2027 and 11,209 shares will vest on May 20, 2028."}],"balance_after":22419,"derivative":{"exercise_price":2.13,"expiration_date":"2035-05-20","underlying":"Common Stock","underlying_shares":22419},"source":{"system":"sec-edgar","filing":"0001055726-25-000041","document":"wk-form4_1747861122.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000041/wk-form4_1747861122.xml","form_type":"4"}},{"id":1139373,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-05-21T20:58:48.000Z","date":"2025-05-20","kind":"grant","planned":false,"acquired":true,"shares":18081,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 18,081 restricted stock units is as follows: 6,027 shares will vest on May 20, 2026; 6,027 shares will vest on May 20, 2027; 6,027 shares will vest on May 20, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 18,081 restricted stock units is as follows: 6,027 shares will vest on May 20, 2026; 6,027 shares will vest on May 20, 2027; 6,027 shares will vest on May 20, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 18,081 restricted stock units is as follows: 6,027 shares will vest on May 20, 2026; 6,027 shares will vest on May 20, 2027; 6,027 shares will vest on May 20, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":18081,"derivative":{"underlying":"Common Stock","underlying_shares":18081},"source":{"system":"sec-edgar","filing":"0001055726-25-000041","document":"wk-form4_1747861122.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000041/wk-form4_1747861122.xml","form_type":"4"}},{"id":1145996,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-05-16T20:08:11.000Z","date":"2025-05-15","kind":"exercise","planned":false,"acquired":false,"shares":4771,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 14,313 restricted stock units is as follows: 4,771 shares vested on May 15, 2024; 4,771 shares vested on May 15, 2025; and 4,771 shares will vest on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 14,313 restricted stock units is as follows: 4,771 shares vested on May 15, 2024; 4,771 shares vested on May 15, 2025; and 4,771 shares will vest on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 14,313 restricted stock units is as follows: 4,771 shares vested on May 15, 2024; 4,771 shares vested on May 15, 2025; and 4,771 shares will vest on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":4771,"derivative":{"underlying":"Common Stock","underlying_shares":4771},"source":{"system":"sec-edgar","filing":"0001055726-25-000028","document":"wk-form4_1747426085.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000028/wk-form4_1747426085.xml","form_type":"4"}},{"id":1145995,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-05-16T20:08:11.000Z","date":"2025-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":1708,"price":1.95,"value":3330.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein."}],"balance_after":32622,"source":{"system":"sec-edgar","filing":"0001055726-25-000028","document":"wk-form4_1747426085.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000028/wk-form4_1747426085.xml","form_type":"4"}},{"id":1145994,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-05-16T20:08:11.000Z","date":"2025-05-15","kind":"exercise","planned":false,"acquired":true,"shares":4771,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 14,313 restricted stock units is as follows: 4,771 shares vested on May 15, 2024; 4,771 shares vested on May 15, 2025; and 4,771 shares will vest on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":34330,"source":{"system":"sec-edgar","filing":"0001055726-25-000028","document":"wk-form4_1747426085.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000028/wk-form4_1747426085.xml","form_type":"4"}},{"id":1239129,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-02-28T23:06:00.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":22098,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 22,098 restricted stock units granted on February 27, 2025 is as follows: 7,366 shares will vest on February 26, 2026; 7,366 shares will vest on February 26, 2027; and 7,366 shares will vest on February 26, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 22,098 restricted stock units granted on February 27, 2025 is as follows: 7,366 shares will vest on February 26, 2026; 7,366 shares will vest on February 26, 2027; and 7,366 shares will vest on February 26, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 22,098 restricted stock units granted on February 27, 2025 is as follows: 7,366 shares will vest on February 26, 2026; 7,366 shares will vest on February 26, 2027; and 7,366 shares will vest on February 26, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":22098,"derivative":{"underlying":"Common Stock","underlying_shares":22098},"source":{"system":"sec-edgar","filing":"0001055726-25-000005","document":"wk-form4_1740783954.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000005/wk-form4_1740783954.xml","form_type":"4"}},{"id":1239128,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock Option","published_at":"2025-02-28T23:06:00.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":27402,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The vesting schedule for the 27,402 options is as follows: 13,701 shares vested on February 27, 2025 and 13,701 shares will vest on February 26, 2026."}],"balance_after":27402,"derivative":{"exercise_price":1.94,"exercise_date":"2025-02-27","expiration_date":"2035-02-27","underlying":"Common Stock","underlying_shares":27402},"source":{"system":"sec-edgar","filing":"0001055726-25-000005","document":"wk-form4_1740783954.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000005/wk-form4_1740783954.xml","form_type":"4"}},{"id":1239127,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-02-28T23:06:00.000Z","date":"2025-02-26","kind":"exercise","planned":false,"acquired":false,"shares":5010,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 15,029 restricted stock units granted on February 28, 2024 is as follows: 5,010 shares vested on February 26, 2025; 5,010 shares will vest on February 26, 2026; and 5,009 shares will vest on February 26, 2027.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 15,029 restricted stock units granted on February 28, 2024 is as follows: 5,010 shares vested on February 26, 2025; 5,010 shares will vest on February 26, 2026; and 5,009 shares will vest on February 26, 2027.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 15,029 restricted stock units granted on February 28, 2024 is as follows: 5,010 shares vested on February 26, 2025; 5,010 shares will vest on February 26, 2026; and 5,009 shares will vest on February 26, 2027.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":10019,"derivative":{"underlying":"Common Stock","underlying_shares":5010},"source":{"system":"sec-edgar","filing":"0001055726-25-000005","document":"wk-form4_1740783954.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000005/wk-form4_1740783954.xml","form_type":"4"}},{"id":1239126,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-02-28T23:06:00.000Z","date":"2025-02-26","kind":"exercise","planned":false,"acquired":false,"shares":3855,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 11,566 restricted stock units granted on February 26, 2022 was as follows: 3,855 shares vested on February 26, 2023; 3,856 shares vested on February 26, 2024; and 3,855 shares vested on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 11,566 restricted stock units granted on February 26, 2022 was as follows: 3,855 shares vested on February 26, 2023; 3,856 shares vested on February 26, 2024; and 3,855 shares vested on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 11,566 restricted stock units granted on February 26, 2022 was as follows: 3,855 shares vested on February 26, 2023; 3,856 shares vested on February 26, 2024; and 3,855 shares vested on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3855},"source":{"system":"sec-edgar","filing":"0001055726-25-000005","document":"wk-form4_1740783954.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000005/wk-form4_1740783954.xml","form_type":"4"}},{"id":1239125,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-02-28T23:06:00.000Z","date":"2025-02-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":2059,"price":1.98,"value":4076.82,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (3) herein."}],"balance_after":29559,"source":{"system":"sec-edgar","filing":"0001055726-25-000005","document":"wk-form4_1740783954.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000005/wk-form4_1740783954.xml","form_type":"4"}},{"id":1239124,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-02-28T23:06:00.000Z","date":"2025-02-26","kind":"exercise","planned":false,"acquired":true,"shares":5010,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 15,029 restricted stock units granted on February 28, 2024 is as follows: 5,010 shares vested on February 26, 2025; 5,010 shares will vest on February 26, 2026; and 5,009 shares will vest on February 26, 2027.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":31618,"source":{"system":"sec-edgar","filing":"0001055726-25-000005","document":"wk-form4_1740783954.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000005/wk-form4_1740783954.xml","form_type":"4"}},{"id":1239123,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-02-28T23:06:00.000Z","date":"2025-02-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":1584,"price":1.98,"value":3136.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein."}],"balance_after":26608,"source":{"system":"sec-edgar","filing":"0001055726-25-000005","document":"wk-form4_1740783954.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000005/wk-form4_1740783954.xml","form_type":"4"}},{"id":1239122,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-02-28T23:06:00.000Z","date":"2025-02-26","kind":"exercise","planned":false,"acquired":true,"shares":3855,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 11,566 restricted stock units granted on February 26, 2022 was as follows: 3,855 shares vested on February 26, 2023; 3,856 shares vested on February 26, 2024; and 3,855 shares vested on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":28192,"source":{"system":"sec-edgar","filing":"0001055726-25-000005","document":"wk-form4_1740783954.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000005/wk-form4_1740783954.xml","form_type":"4"}},{"id":1514766,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-05-16T21:08:13.000Z","date":"2024-05-15","kind":"exercise","planned":false,"acquired":false,"shares":4771,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 14,313 restricted stock units is as follows: 4,771 shares vested on May 15, 2024; 4,771 shares will vest on May 15, 2025; and 4,771 shares will vest on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"shares","element":"transactionShares","label":"F2","text":"Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 14,313 restricted stock units is as follows: 4,771 shares vested on May 15, 2024; 4,771 shares will vest on May 15, 2025; and 4,771 shares will vest on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 14,313 restricted stock units is as follows: 4,771 shares vested on May 15, 2024; 4,771 shares will vest on May 15, 2025; and 4,771 shares will vest on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024."}],"balance_after":9542,"derivative":{"underlying":"Common Stock","underlying_shares":4771},"source":{"system":"sec-edgar","filing":"0001055726-24-000030","document":"wk-form4_1715893678.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572624000030/wk-form4_1715893678.xml","form_type":"4"}},{"id":1514765,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-05-16T21:08:13.000Z","date":"2024-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":1703,"price":13.07,"value":22258.21,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein."}],"balance_after":24337,"source":{"system":"sec-edgar","filing":"0001055726-24-000030","document":"wk-form4_1715893678.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572624000030/wk-form4_1715893678.xml","form_type":"4"}},{"id":1514764,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-05-16T21:08:13.000Z","date":"2024-05-15","kind":"exercise","planned":false,"acquired":true,"shares":4771,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 14,313 restricted stock units is as follows: 4,771 shares vested on May 15, 2024; 4,771 shares will vest on May 15, 2025; and 4,771 shares will vest on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024."}],"balance_after":26040,"source":{"system":"sec-edgar","filing":"0001055726-24-000030","document":"wk-form4_1715893678.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572624000030/wk-form4_1715893678.xml","form_type":"4"}},{"id":1613102,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-02-28T22:07:53.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":15029,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 15,029 restricted stock units is as follows: 5,010 shares will vest on February 26, 2025; 5,010 shares will vest on February 26, 2026; and 5,009 shares will vest on February 26, 2027.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 15,029 restricted stock units is as follows: 5,010 shares will vest on February 26, 2025; 5,010 shares will vest on February 26, 2026; and 5,009 shares will vest on February 26, 2027.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 15,029 restricted stock units is as follows: 5,010 shares will vest on February 26, 2025; 5,010 shares will vest on February 26, 2026; and 5,009 shares will vest on February 26, 2027.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":15029,"derivative":{"underlying":"Common Stock","underlying_shares":15029},"source":{"system":"sec-edgar","filing":"0001055726-24-000004","document":"wk-form4_1709158046.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572624000004/wk-form4_1709158046.xml","form_type":"4"}},{"id":1613101,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock Option","published_at":"2024-02-28T22:07:53.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The vesting schedule for the 18,750 options is as follows: 4,688 shares vested on February 28, 2024; 4,688 shares will vest on February 28, 2025; 4,687 shares will vest on February 28, 2026; and 4,687 shares will vest on February 28, 2027."}],"balance_after":18750,"derivative":{"exercise_price":8.46,"exercise_date":"2024-02-28","expiration_date":"2034-02-28","underlying":"Common Stock","underlying_shares":18750},"source":{"system":"sec-edgar","filing":"0001055726-24-000004","document":"wk-form4_1709158046.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572624000004/wk-form4_1709158046.xml","form_type":"4"}},{"id":1613100,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-02-28T22:07:53.000Z","date":"2024-02-26","kind":"exercise","planned":false,"acquired":false,"shares":3856,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 11,566 restricted stock units is as follows: 3,855 shares vested on February 26, 2023; 3,856 shares vested on February 26, 2024; and 3,855 shares will vest on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"shares","element":"transactionShares","label":"F2","text":"Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 11,566 restricted stock units is as follows: 3,855 shares vested on February 26, 2023; 3,856 shares vested on February 26, 2024; and 3,855 shares will vest on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 11,566 restricted stock units is as follows: 3,855 shares vested on February 26, 2023; 3,856 shares vested on February 26, 2024; and 3,855 shares will vest on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024."}],"balance_after":3855,"derivative":{"underlying":"Common Stock","underlying_shares":3856},"source":{"system":"sec-edgar","filing":"0001055726-24-000004","document":"wk-form4_1709158046.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572624000004/wk-form4_1709158046.xml","form_type":"4"}},{"id":1613099,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-02-28T22:07:53.000Z","date":"2024-02-26","kind":"exercise","planned":false,"acquired":false,"shares":1878,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 5,635 restricted stock units was as follows: 1,879 shares vested on February 26, 2022; 1,878 shares vested on February 26, 2023; and 1,878 shares vested on February 26, 2024.  Vested restricted stock units could be settled in shares of common stock, cash or a combination of both."},{"field":"shares","element":"transactionShares","label":"F2","text":"Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 5,635 restricted stock units was as follows: 1,879 shares vested on February 26, 2022; 1,878 shares vested on February 26, 2023; and 1,878 shares vested on February 26, 2024.  Vested restricted stock units could be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 5,635 restricted stock units was as follows: 1,879 shares vested on February 26, 2022; 1,878 shares vested on February 26, 2023; and 1,878 shares vested on February 26, 2024.  Vested restricted stock units could be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1878},"source":{"system":"sec-edgar","filing":"0001055726-24-000004","document":"wk-form4_1709158046.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572624000004/wk-form4_1709158046.xml","form_type":"4"}},{"id":1613098,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-02-28T22:07:53.000Z","date":"2024-02-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":1581,"price":8.16,"value":12900.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (4) herein."}],"balance_after":21269,"source":{"system":"sec-edgar","filing":"0001055726-24-000004","document":"wk-form4_1709158046.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572624000004/wk-form4_1709158046.xml","form_type":"4"}},{"id":1613097,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-02-28T22:07:53.000Z","date":"2024-02-26","kind":"exercise","planned":false,"acquired":true,"shares":3856,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 11,566 restricted stock units is as follows: 3,855 shares vested on February 26, 2023; 3,856 shares vested on February 26, 2024; and 3,855 shares will vest on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":22850,"source":{"system":"sec-edgar","filing":"0001055726-24-000004","document":"wk-form4_1709158046.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572624000004/wk-form4_1709158046.xml","form_type":"4"}},{"id":1613096,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-02-28T22:07:53.000Z","date":"2024-02-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":770,"price":8.16,"value":6283.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein."}],"balance_after":18994,"source":{"system":"sec-edgar","filing":"0001055726-24-000004","document":"wk-form4_1709158046.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572624000004/wk-form4_1709158046.xml","form_type":"4"}},{"id":1613095,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-02-28T22:07:53.000Z","date":"2024-02-26","kind":"exercise","planned":false,"acquired":true,"shares":1878,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 5,635 restricted stock units was as follows: 1,879 shares vested on February 26, 2022; 1,878 shares vested on February 26, 2023; and 1,878 shares vested on February 26, 2024.  Vested restricted stock units could be settled in shares of common stock, cash or a combination of both."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024."}],"balance_after":19764,"source":{"system":"sec-edgar","filing":"0001055726-24-000004","document":"wk-form4_1709158046.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572624000004/wk-form4_1709158046.xml","form_type":"4"}},{"id":1889806,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Unit","published_at":"2023-05-17T20:11:31.000Z","date":"2023-05-15","kind":"grant","planned":false,"acquired":true,"shares":171756,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 171,756 restricted stock units is as follows: 57,252 shares will vest on May 15, 2024; 57,252 shares will vest on May 15, 2025; and 57,252 shares will vest on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"shares","element":"transactionShares","label":"F2","text":"This grant was made under the 2016 Omnibus Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 171,756 restricted stock units is as follows: 57,252 shares will vest on May 15, 2024; 57,252 shares will vest on May 15, 2025; and 57,252 shares will vest on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 171,756 restricted stock units is as follows: 57,252 shares will vest on May 15, 2024; 57,252 shares will vest on May 15, 2025; and 57,252 shares will vest on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":171756,"derivative":{"underlying":"Common Stock","underlying_shares":171756},"source":{"system":"sec-edgar","filing":"0001055726-23-000042","document":"wk-form4_1684354280.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572623000042/wk-form4_1684354280.xml","form_type":"4"}},{"id":1957223,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Unit","published_at":"2023-03-13T21:09:02.000Z","date":"2023-03-11","kind":"exercise","acquired":false,"shares":59737,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. On March 11, 2020, the reporting person was granted 179,211 restricted stock units, vesting as follows: 59,737 shares vested on March 11, 2021; 59,737 shares vested on March 11, 2022; and 59,737 shares vested on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. On March 11, 2020, the reporting person was granted 179,211 restricted stock units, vesting as follows: 59,737 shares vested on March 11, 2021; 59,737 shares vested on March 11, 2022; and 59,737 shares vested on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. On March 11, 2020, the reporting person was granted 179,211 restricted stock units, vesting as follows: 59,737 shares vested on March 11, 2021; 59,737 shares vested on March 11, 2022; and 59,737 shares vested on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":59737},"source":{"system":"sec-edgar","filing":"0001055726-23-000013","document":"wf-form4_167874172348787.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572623000013/wf-form4_167874172348787.xml","form_type":"4"}},{"id":1957222,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-03-13T21:09:02.000Z","date":"2023-03-11","kind":"tax_withholding","acquired":false,"shares":20658,"price":1.13,"value":23343.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein."}],"balance_after":214637,"source":{"system":"sec-edgar","filing":"0001055726-23-000013","document":"wf-form4_167874172348787.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572623000013/wf-form4_167874172348787.xml","form_type":"4"}},{"id":1957221,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-03-13T21:09:02.000Z","date":"2023-03-11","kind":"exercise","acquired":true,"shares":59737,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. On March 11, 2020, the reporting person was granted 179,211 restricted stock units, vesting as follows: 59,737 shares vested on March 11, 2021; 59,737 shares vested on March 11, 2022; and 59,737 shares vested on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":235295,"source":{"system":"sec-edgar","filing":"0001055726-23-000013","document":"wf-form4_167874172348787.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572623000013/wf-form4_167874172348787.xml","form_type":"4"}},{"id":1987904,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock Option","published_at":"2023-02-28T22:43:17.000Z","date":"2023-02-27","kind":"grant","acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The vesting schedule for the 225,000 options is as follows: 56,250 shares vested on February 27, 2023; 56,250 shares will vest on February 26, 2024; 56,250 shares will vest on February 26, 2025; and 56,250 shares will vest on February 26, 2026."}],"balance_after":225000,"derivative":{"exercise_price":1.24,"exercise_date":"2023-02-27","expiration_date":"2033-02-27","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001055726-23-000006","document":"wf-form4_167762417016584.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572623000006/wf-form4_167762417016584.xml","form_type":"4"}},{"id":1987903,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Unit","published_at":"2023-02-28T22:43:17.000Z","date":"2023-02-26","kind":"exercise","acquired":false,"shares":46267,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. On February 26, 2022, the reporting person was granted 138,800 restricted stock units, vesting as follows: 46,267 shares vested on February 26, 2023; 46,267 shares will vest on February 26, 2024; and 46,266 shares will vest on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. On February 26, 2022, the reporting person was granted 138,800 restricted stock units, vesting as follows: 46,267 shares vested on February 26, 2023; 46,267 shares will vest on February 26, 2024; and 46,266 shares will vest on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. On February 26, 2022, the reporting person was granted 138,800 restricted stock units, vesting as follows: 46,267 shares vested on February 26, 2023; 46,267 shares will vest on February 26, 2024; and 46,266 shares will vest on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":92533,"derivative":{"underlying":"Common Stock","underlying_shares":46267},"source":{"system":"sec-edgar","filing":"0001055726-23-000006","document":"wf-form4_167762417016584.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572623000006/wf-form4_167762417016584.xml","form_type":"4"}},{"id":1987902,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Unit","published_at":"2023-02-28T22:43:17.000Z","date":"2023-02-26","kind":"exercise","acquired":false,"shares":22544,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  On February 26, 2021, the reporting person was granted 67,633 restricted stock units, vesting as follows: 22,545 shares vested on February 26, 2022; 22,544 shares vested on February 26, 2023; and 22,544 shares will vest on February 26, 2024.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  On February 26, 2021, the reporting person was granted 67,633 restricted stock units, vesting as follows: 22,545 shares vested on February 26, 2022; 22,544 shares vested on February 26, 2023; and 22,544 shares will vest on February 26, 2024.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  On February 26, 2021, the reporting person was granted 67,633 restricted stock units, vesting as follows: 22,545 shares vested on February 26, 2022; 22,544 shares vested on February 26, 2023; and 22,544 shares will vest on February 26, 2024.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":22544,"derivative":{"underlying":"Common Stock","underlying_shares":22544},"source":{"system":"sec-edgar","filing":"0001055726-23-000006","document":"wf-form4_167762417016584.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572623000006/wf-form4_167762417016584.xml","form_type":"4"}},{"id":1987901,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-02-28T22:43:17.000Z","date":"2023-02-26","kind":"tax_withholding","acquired":false,"shares":18868,"price":1.28,"value":24151.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (3) herein."}],"balance_after":175558,"source":{"system":"sec-edgar","filing":"0001055726-23-000006","document":"wf-form4_167762417016584.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572623000006/wf-form4_167762417016584.xml","form_type":"4"}},{"id":1987900,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-02-28T22:43:17.000Z","date":"2023-02-26","kind":"exercise","acquired":true,"shares":46267,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. On February 26, 2022, the reporting person was granted 138,800 restricted stock units, vesting as follows: 46,267 shares vested on February 26, 2023; 46,267 shares will vest on February 26, 2024; and 46,266 shares will vest on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":194426,"source":{"system":"sec-edgar","filing":"0001055726-23-000006","document":"wf-form4_167762417016584.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572623000006/wf-form4_167762417016584.xml","form_type":"4"}},{"id":1987899,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-02-28T22:43:17.000Z","date":"2023-02-26","kind":"tax_withholding","acquired":false,"shares":9069,"price":1.28,"value":11608.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein."}],"balance_after":148159,"source":{"system":"sec-edgar","filing":"0001055726-23-000006","document":"wf-form4_167762417016584.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572623000006/wf-form4_167762417016584.xml","form_type":"4"}},{"id":1987898,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-02-28T22:43:17.000Z","date":"2023-02-26","kind":"exercise","acquired":true,"shares":22544,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  On February 26, 2021, the reporting person was granted 67,633 restricted stock units, vesting as follows: 22,545 shares vested on February 26, 2022; 22,544 shares vested on February 26, 2023; and 22,544 shares will vest on February 26, 2024.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":157228,"source":{"system":"sec-edgar","filing":"0001055726-23-000006","document":"wf-form4_167762417016584.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572623000006/wf-form4_167762417016584.xml","form_type":"4"}},{"id":2336154,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-03-14T20:51:39.000Z","date":"2022-03-11","kind":"exercise","acquired":false,"shares":59737,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 179,211 restricted stock units is as follows: 59,737 shares vested on March 11, 2021; 59,737 shares vested on March 11, 2022; 59,737 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 179,211 restricted stock units is as follows: 59,737 shares vested on March 11, 2021; 59,737 shares vested on March 11, 2022; 59,737 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 179,211 restricted stock units is as follows: 59,737 shares vested on March 11, 2021; 59,737 shares vested on March 11, 2022; 59,737 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 179,211 restricted stock units is as follows: 59,737 shares vested on March 11, 2021; 59,737 shares vested on March 11, 2022; 59,737 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":59737,"derivative":{"underlying":"Common Stock","underlying_shares":59737},"source":{"system":"sec-edgar","filing":"0001055726-22-000024","document":"wf-form4_164729099179365.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000024/wf-form4_164729099179365.xml","form_type":"4"}},{"id":2336153,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-03-14T20:51:39.000Z","date":"2022-03-11","kind":"tax_withholding","acquired":false,"shares":20658,"price":3.22,"value":66518.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein."}],"balance_after":134684,"source":{"system":"sec-edgar","filing":"0001055726-22-000024","document":"wf-form4_164729099179365.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000024/wf-form4_164729099179365.xml","form_type":"4"}},{"id":2336152,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-03-14T20:51:39.000Z","date":"2022-03-11","kind":"exercise","acquired":true,"shares":59737,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 179,211 restricted stock units is as follows: 59,737 shares vested on March 11, 2021; 59,737 shares vested on March 11, 2022; 59,737 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":155342,"source":{"system":"sec-edgar","filing":"0001055726-22-000024","document":"wf-form4_164729099179365.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000024/wf-form4_164729099179365.xml","form_type":"4"}},{"id":2336151,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-03-14T20:50:24.000Z","date":"2022-03-11","kind":"exercise","acquired":false,"shares":59737,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 179,211 restricted stock units is as follows: 59,737 shares vested on March 11, 2021; 59,737 shares vested on March 11, 2022; 59,737 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 179,211 restricted stock units is as follows: 59,737 shares vested on March 11, 2021; 59,737 shares vested on March 11, 2022; 59,737 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 179,211 restricted stock units is as follows: 59,737 shares vested on March 11, 2021; 59,737 shares vested on March 11, 2022; 59,737 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 179,211 restricted stock units is as follows: 59,737 shares vested on March 11, 2021; 59,737 shares vested on March 11, 2022; 59,737 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":59737,"derivative":{"underlying":"Common Stock","underlying_shares":59737},"source":{"system":"sec-edgar","filing":"0001055726-22-000023","document":"wf-form4_164729088600390.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000023/wf-form4_164729088600390.xml","form_type":"4"}},{"id":2336150,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-03-14T20:50:24.000Z","date":"2022-03-11","kind":"tax_withholding","acquired":false,"shares":20658,"price":3.22,"value":66518.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein."}],"balance_after":134684,"source":{"system":"sec-edgar","filing":"0001055726-22-000023","document":"wf-form4_164729088600390.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000023/wf-form4_164729088600390.xml","form_type":"4"}},{"id":2336149,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-03-14T20:50:24.000Z","date":"2022-03-11","kind":"exercise","acquired":true,"shares":59737,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 179,211 restricted stock units is as follows: 59,737 shares vested on March 11, 2021; 59,737 shares vested on March 11, 2022; 59,737 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":155342,"source":{"system":"sec-edgar","filing":"0001055726-22-000023","document":"wf-form4_164729088600390.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000023/wf-form4_164729088600390.xml","form_type":"4"}},{"id":2342471,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-03-09T21:06:28.000Z","date":"2022-03-08","kind":"exercise","acquired":false,"shares":19900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 59,700 restricted stock units is as follows: 19,900 shares vested on March 8, 2020; 19,900 shares vested on March 8, 2021; 19,900 shares vested on March 8, 2022.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 59,700 restricted stock units is as follows: 19,900 shares vested on March 8, 2020; 19,900 shares vested on March 8, 2021; 19,900 shares vested on March 8, 2022.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 59,700 restricted stock units is as follows: 19,900 shares vested on March 8, 2020; 19,900 shares vested on March 8, 2021; 19,900 shares vested on March 8, 2022.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 59,700 restricted stock units is as follows: 19,900 shares vested on March 8, 2020; 19,900 shares vested on March 8, 2021; 19,900 shares vested on March 8, 2022.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":19900},"source":{"system":"sec-edgar","filing":"0001055726-22-000015","document":"wf-form4_164685997301367.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000015/wf-form4_164685997301367.xml","form_type":"4"}},{"id":2342470,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-03-09T21:06:28.000Z","date":"2022-03-08","kind":"tax_withholding","acquired":false,"shares":6882,"price":3.26,"value":22435.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein."}],"balance_after":95605,"source":{"system":"sec-edgar","filing":"0001055726-22-000015","document":"wf-form4_164685997301367.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000015/wf-form4_164685997301367.xml","form_type":"4"}},{"id":2342469,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-03-09T21:06:28.000Z","date":"2022-03-08","kind":"exercise","acquired":true,"shares":19900,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 59,700 restricted stock units is as follows: 19,900 shares vested on March 8, 2020; 19,900 shares vested on March 8, 2021; 19,900 shares vested on March 8, 2022.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":102487,"source":{"system":"sec-edgar","filing":"0001055726-22-000015","document":"wf-form4_164685997301367.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000015/wf-form4_164685997301367.xml","form_type":"4"}},{"id":2366343,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-03-01T23:48:43.000Z","date":"2022-02-26","kind":"grant","acquired":true,"shares":138800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 138,800 restricted stock units is as follows: 46,267 shares will vest on February 26, 2023; 46,267 shares will vest on February 26, 2024; 46,266 shares will vest on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 138,800 restricted stock units is as follows: 46,267 shares will vest on February 26, 2023; 46,267 shares will vest on February 26, 2024; 46,266 shares will vest on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 138,800 restricted stock units is as follows: 46,267 shares will vest on February 26, 2023; 46,267 shares will vest on February 26, 2024; 46,266 shares will vest on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 138,800 restricted stock units is as follows: 46,267 shares will vest on February 26, 2023; 46,267 shares will vest on February 26, 2024; 46,266 shares will vest on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":138800,"derivative":{"underlying":"Common Stock","underlying_shares":138800},"source":{"system":"sec-edgar","filing":"0001055726-22-000011","document":"wf-form4_164617848636087.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000011/wf-form4_164617848636087.xml","form_type":"4"}},{"id":2366342,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock Option","published_at":"2022-03-01T23:48:43.000Z","date":"2022-02-26","kind":"grant","acquired":true,"shares":186000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The vesting schedule for the 186,000 options is as follows: 46,500 shares vested on February 26, 2022; 46,500 shares will vest on February 26, 2023; 46,500 shares will vest on February 26, 2024; 46,500 shares will vest on February 26, 2025."}],"balance_after":186000,"derivative":{"exercise_price":3.22,"exercise_date":"2022-02-26","expiration_date":"2032-02-26","underlying":"Common Stock","underlying_shares":186000},"source":{"system":"sec-edgar","filing":"0001055726-22-000011","document":"wf-form4_164617848636087.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000011/wf-form4_164617848636087.xml","form_type":"4"}},{"id":2366341,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-03-01T23:48:43.000Z","date":"2022-02-26","kind":"exercise","acquired":false,"shares":22545,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 67,633 restricted stock units is as follows: 22,545 shares vested on February 26, 2022; 22,544 shares will vest on February 26, 2023; 22,544 shares will vest on February 26, 2024.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 67,633 restricted stock units is as follows: 22,545 shares vested on February 26, 2022; 22,544 shares will vest on February 26, 2023; 22,544 shares will vest on February 26, 2024.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 67,633 restricted stock units is as follows: 22,545 shares vested on February 26, 2022; 22,544 shares will vest on February 26, 2023; 22,544 shares will vest on February 26, 2024.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 67,633 restricted stock units is as follows: 22,545 shares vested on February 26, 2022; 22,544 shares will vest on February 26, 2023; 22,544 shares will vest on February 26, 2024.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":45088,"derivative":{"underlying":"Common Stock","underlying_shares":22545},"source":{"system":"sec-edgar","filing":"0001055726-22-000011","document":"wf-form4_164617848636087.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000011/wf-form4_164617848636087.xml","form_type":"4"}},{"id":2366340,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-03-01T23:48:43.000Z","date":"2022-02-26","kind":"tax_withholding","acquired":false,"shares":8545,"price":3.22,"value":27514.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein."}],"balance_after":82587,"source":{"system":"sec-edgar","filing":"0001055726-22-000011","document":"wf-form4_164617848636087.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000011/wf-form4_164617848636087.xml","form_type":"4"}},{"id":2366339,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-03-01T23:48:43.000Z","date":"2022-02-26","kind":"exercise","acquired":true,"shares":22545,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 67,633 restricted stock units is as follows: 22,545 shares vested on February 26, 2022; 22,544 shares will vest on February 26, 2023; 22,544 shares will vest on February 26, 2024.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":91132,"source":{"system":"sec-edgar","filing":"0001055726-22-000011","document":"wf-form4_164617848636087.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000011/wf-form4_164617848636087.xml","form_type":"4"}},{"id":2607398,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-08-11T20:03:53.000Z","date":"2021-08-09","kind":"sale","acquired":false,"shares":10317,"price":9.15,"value":94400.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These transactions were executed in multiple trades at prices ranging from $9.08 to $9.22, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":68587,"source":{"system":"sec-edgar","filing":"0001055726-21-000056","document":"wf-form4_162871220754102.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000056/wf-form4_162871220754102.xml","form_type":"4"}},{"id":2672505,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-06-11T20:25:53.000Z","date":"2021-06-09","kind":"sale","acquired":false,"shares":10318,"price":9.07,"value":93584.26,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These transactions were executed in multiple trades at prices ranging from $8.91 to $9.22, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":78904,"source":{"system":"sec-edgar","filing":"0001055726-21-000051","document":"wf-form4_162344313045015.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000051/wf-form4_162344313045015.xml","form_type":"4"}},{"id":2792726,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Unit","published_at":"2021-03-12T23:35:14.000Z","date":"2021-03-11","kind":"exercise","acquired":false,"shares":59737,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 179,211 restricted stock units is as follows: 59,737 shares vested on March 11, 2021; 59,737 shares will vest on March 11, 2022; 59,737 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 179,211 restricted stock units is as follows: 59,737 shares vested on March 11, 2021; 59,737 shares will vest on March 11, 2022; 59,737 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 179,211 restricted stock units is as follows: 59,737 shares vested on March 11, 2021; 59,737 shares will vest on March 11, 2022; 59,737 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 179,211 restricted stock units is as follows: 59,737 shares vested on March 11, 2021; 59,737 shares will vest on March 11, 2022; 59,737 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":119474,"derivative":{"underlying":"Common Stock","underlying_shares":59737},"source":{"system":"sec-edgar","filing":"0001055726-21-000026","document":"wf-form4_161559209855704.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000026/wf-form4_161559209855704.xml","form_type":"4"}},{"id":2792725,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-03-12T23:35:14.000Z","date":"2021-03-11","kind":"tax_withholding","acquired":false,"shares":25967,"price":10.57,"value":274471.19,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein."}],"balance_after":89222,"source":{"system":"sec-edgar","filing":"0001055726-21-000026","document":"wf-form4_161559209855704.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000026/wf-form4_161559209855704.xml","form_type":"4"}},{"id":2792724,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-03-12T23:35:14.000Z","date":"2021-03-11","kind":"exercise","acquired":true,"shares":59737,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 179,211 restricted stock units is as follows: 59,737 shares vested on March 11, 2021; 59,737 shares will vest on March 11, 2022; 59,737 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":115189,"source":{"system":"sec-edgar","filing":"0001055726-21-000026","document":"wf-form4_161559209855704.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000026/wf-form4_161559209855704.xml","form_type":"4"}},{"id":2800861,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Unit","published_at":"2021-03-10T00:04:35.000Z","date":"2021-03-08","kind":"exercise","acquired":false,"shares":19900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 59,700 restricted stock units is as follows: 19,900 shares vested on March 8, 2020; 19,900 shares vested on March 8, 2021; 19,900 shares will vest on March 10, 2022.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 59,700 restricted stock units is as follows: 19,900 shares vested on March 8, 2020; 19,900 shares vested on March 8, 2021; 19,900 shares will vest on March 10, 2022.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 59,700 restricted stock units is as follows: 19,900 shares vested on March 8, 2020; 19,900 shares vested on March 8, 2021; 19,900 shares will vest on March 10, 2022.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 59,700 restricted stock units is as follows: 19,900 shares vested on March 8, 2020; 19,900 shares vested on March 8, 2021; 19,900 shares will vest on March 10, 2022.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":19900,"derivative":{"underlying":"Common Stock","underlying_shares":19900},"source":{"system":"sec-edgar","filing":"0001055726-21-000021","document":"wf-form4_161533465915024.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000021/wf-form4_161533465915024.xml","form_type":"4"}},{"id":2800860,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Unit","published_at":"2021-03-10T00:04:35.000Z","date":"2021-03-05","kind":"exercise","acquired":false,"shares":27566,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 82,700 restricted stock units is as follows: 27,567 shares vested on March 5, 2019; 27,567 shares vested on March 5, 2020; 27,566 shares vested on March 5, 2021.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 82,700 restricted stock units is as follows: 27,567 shares vested on March 5, 2019; 27,567 shares vested on March 5, 2020; 27,566 shares vested on March 5, 2021.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 82,700 restricted stock units is as follows: 27,567 shares vested on March 5, 2019; 27,567 shares vested on March 5, 2020; 27,566 shares vested on March 5, 2021.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 82,700 restricted stock units is as follows: 27,567 shares vested on March 5, 2019; 27,567 shares vested on March 5, 2020; 27,566 shares vested on March 5, 2021.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":27566},"source":{"system":"sec-edgar","filing":"0001055726-21-000021","document":"wf-form4_161533465915024.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000021/wf-form4_161533465915024.xml","form_type":"4"}},{"id":2800859,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-03-10T00:04:35.000Z","date":"2021-03-08","kind":"tax_withholding","acquired":false,"shares":6882,"price":8.91,"value":61318.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (3) herein."}],"balance_after":55452,"source":{"system":"sec-edgar","filing":"0001055726-21-000021","document":"wf-form4_161533465915024.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000021/wf-form4_161533465915024.xml","form_type":"4"}},{"id":2800858,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-03-10T00:04:35.000Z","date":"2021-03-08","kind":"exercise","acquired":true,"shares":19900,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 59,700 restricted stock units is as follows: 19,900 shares vested on March 8, 2020; 19,900 shares vested on March 8, 2021; 19,900 shares will vest on March 10, 2022.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":62334,"source":{"system":"sec-edgar","filing":"0001055726-21-000021","document":"wf-form4_161533465915024.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000021/wf-form4_161533465915024.xml","form_type":"4"}},{"id":2800857,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-03-10T00:04:35.000Z","date":"2021-03-05","kind":"tax_withholding","acquired":false,"shares":9632,"price":9.19,"value":88518.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein."}],"balance_after":42434,"source":{"system":"sec-edgar","filing":"0001055726-21-000021","document":"wf-form4_161533465915024.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000021/wf-form4_161533465915024.xml","form_type":"4"}},{"id":2800856,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-03-10T00:04:35.000Z","date":"2021-03-05","kind":"exercise","acquired":true,"shares":27566,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 82,700 restricted stock units is as follows: 27,567 shares vested on March 5, 2019; 27,567 shares vested on March 5, 2020; 27,566 shares vested on March 5, 2021.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":52066,"source":{"system":"sec-edgar","filing":"0001055726-21-000021","document":"wf-form4_161533465915024.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000021/wf-form4_161533465915024.xml","form_type":"4"}},{"id":2830313,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Unit","published_at":"2021-02-27T00:06:41.000Z","date":"2021-02-26","kind":"grant","acquired":true,"shares":67633,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 67,633 restricted stock units is as follows: 22,544 shares will vest on February 26, 2022; 22,544 shares will vest on February 26, 2023; 22,545 shares will vest on February 26, 2024.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 67,633 restricted stock units is as follows: 22,544 shares will vest on February 26, 2022; 22,544 shares will vest on February 26, 2023; 22,545 shares will vest on February 26, 2024.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 67,633 restricted stock units is as follows: 22,544 shares will vest on February 26, 2022; 22,544 shares will vest on February 26, 2023; 22,545 shares will vest on February 26, 2024.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":67633,"derivative":{"underlying":"Common Stock","underlying_shares":67633},"source":{"system":"sec-edgar","filing":"0001055726-21-000012","document":"wf-form4_161438435223003.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000012/wf-form4_161438435223003.xml","form_type":"4"}},{"id":2830312,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock Option","published_at":"2021-02-27T00:06:41.000Z","date":"2021-02-26","kind":"grant","acquired":true,"shares":104833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The vesting schedule for the 104,833 options is as follows: 26,208 shares vested on February 26, 2021; 26,208 shares will vest on February 26, 2022; 26,208 shares will vest on February 26, 2023; 26,209 shares will vest on February 26, 2024."}],"balance_after":104833,"derivative":{"exercise_price":11.1,"exercise_date":"2021-02-26","expiration_date":"2031-02-26","underlying":"Common Stock","underlying_shares":104833},"source":{"system":"sec-edgar","filing":"0001055726-21-000012","document":"wf-form4_161438435223003.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000012/wf-form4_161438435223003.xml","form_type":"4"}},{"id":2984416,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-11-12T21:21:28.000Z","date":"2020-11-10","kind":"sale","acquired":false,"shares":19466,"price":9.75,"value":189793.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These transactions were executed in multiple trades at prices ranging from $8.98 to $9.91, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":24500,"source":{"system":"sec-edgar","filing":"0001055726-20-000053","document":"wf-form4_160521606503922.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000053/wf-form4_160521606503922.xml","form_type":"4"}},{"id":3060657,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-08-12T22:59:25.000Z","date":"2020-08-10","kind":"sale","acquired":false,"shares":19467,"price":19.0581,"value":371004.0327,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These transactions were executed in multiple trades at prices ranging from $18.54 to $19.63, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":43966,"source":{"system":"sec-edgar","filing":"0001055726-20-000049","document":"wf-form4_159727315173572.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000049/wf-form4_159727315173572.xml","form_type":"4"}},{"id":3101096,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-06-24T20:56:12.000Z","date":"2020-06-22","kind":"sale","acquired":false,"shares":19467,"price":14.7,"value":286164.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":63433,"source":{"system":"sec-edgar","filing":"0001055726-20-000042","document":"wf-form4_159303215471263.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000042/wf-form4_159303215471263.xml","form_type":"4"}},{"id":3213973,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Unit","published_at":"2020-03-12T20:43:25.000Z","date":"2020-03-11","kind":"grant","acquired":true,"shares":179211,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 179,211 restricted stock units is as follows: 59,737 shares will vest on March 11, 2021; 59,737 shares will vest on March 11, 2022; 59,737 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 179,211 restricted stock units is as follows: 59,737 shares will vest on March 11, 2021; 59,737 shares will vest on March 11, 2022; 59,737 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 179,211 restricted stock units is as follows: 59,737 shares will vest on March 11, 2021; 59,737 shares will vest on March 11, 2022; 59,737 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":179211,"derivative":{"underlying":"Common Stock","underlying_shares":179211},"source":{"system":"sec-edgar","filing":"0001055726-20-000015","document":"wf-form4_158404578720195.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000015/wf-form4_158404578720195.xml","form_type":"4"}},{"id":3213972,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Unit","published_at":"2020-03-12T20:43:25.000Z","date":"2020-03-10","kind":"exercise","acquired":false,"shares":2812,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 5,624 restricted stock units is as follows: 2,812 shares vested on March 10, 2019; 2,812 shares vested on March 10, 2020. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 5,624 restricted stock units is as follows: 2,812 shares vested on March 10, 2019; 2,812 shares vested on March 10, 2020. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 5,624 restricted stock units is as follows: 2,812 shares vested on March 10, 2019; 2,812 shares vested on March 10, 2020. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 5,624 restricted stock units is as follows: 2,812 shares vested on March 10, 2019; 2,812 shares vested on March 10, 2020. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2812},"source":{"system":"sec-edgar","filing":"0001055726-20-000015","document":"wf-form4_158404578720195.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000015/wf-form4_158404578720195.xml","form_type":"4"}},{"id":3213971,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-03-12T20:43:25.000Z","date":"2020-03-10","kind":"tax_withholding","acquired":false,"shares":973,"price":5.7,"value":5546.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein."}],"balance_after":82900,"source":{"system":"sec-edgar","filing":"0001055726-20-000015","document":"wf-form4_158404578720195.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000015/wf-form4_158404578720195.xml","form_type":"4"}},{"id":3213970,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-03-12T20:43:25.000Z","date":"2020-03-10","kind":"exercise","acquired":true,"shares":2812,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 5,624 restricted stock units is as follows: 2,812 shares vested on March 10, 2019; 2,812 shares vested on March 10, 2020. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":83873,"source":{"system":"sec-edgar","filing":"0001055726-20-000015","document":"wf-form4_158404578720195.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000015/wf-form4_158404578720195.xml","form_type":"4"}},{"id":3221031,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Unit","published_at":"2020-03-09T20:16:49.000Z","date":"2020-03-08","kind":"exercise","acquired":false,"shares":19900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 59,700 restricted stock units is as follows: 19,900 shares vested on March 8, 2020; 19,900 shares will vest on March 8, 2021; 19,900 shares will vest on March 8, 2022.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 59,700 restricted stock units is as follows: 19,900 shares vested on March 8, 2020; 19,900 shares will vest on March 8, 2021; 19,900 shares will vest on March 8, 2022.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 59,700 restricted stock units is as follows: 19,900 shares vested on March 8, 2020; 19,900 shares will vest on March 8, 2021; 19,900 shares will vest on March 8, 2022.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 59,700 restricted stock units is as follows: 19,900 shares vested on March 8, 2020; 19,900 shares will vest on March 8, 2021; 19,900 shares will vest on March 8, 2022.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":39800,"derivative":{"underlying":"Common Stock","underlying_shares":19900},"source":{"system":"sec-edgar","filing":"0001055726-20-000007","document":"wf-form4_158378499078811.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000007/wf-form4_158378499078811.xml","form_type":"4"}},{"id":3221030,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Unit","published_at":"2020-03-09T20:16:49.000Z","date":"2020-03-05","kind":"exercise","acquired":false,"shares":27567,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 82,700 restricted stock units is as follows: 27,567 shares vested on March 5, 2019; 27,567 shares vested on March 5, 2020; 27,566 shares will vest on March 5, 2021.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 82,700 restricted stock units is as follows: 27,567 shares vested on March 5, 2019; 27,567 shares vested on March 5, 2020; 27,566 shares will vest on March 5, 2021.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 82,700 restricted stock units is as follows: 27,567 shares vested on March 5, 2019; 27,567 shares vested on March 5, 2020; 27,566 shares will vest on March 5, 2021.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 82,700 restricted stock units is as follows: 27,567 shares vested on March 5, 2019; 27,567 shares vested on March 5, 2020; 27,566 shares will vest on March 5, 2021.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":27566,"derivative":{"underlying":"Common Stock","underlying_shares":27567},"source":{"system":"sec-edgar","filing":"0001055726-20-000007","document":"wf-form4_158378499078811.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000007/wf-form4_158378499078811.xml","form_type":"4"}},{"id":3221029,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-03-09T20:16:49.000Z","date":"2020-03-08","kind":"tax_withholding","acquired":false,"shares":6882,"price":14.09,"value":96967.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (3) herein."}],"balance_after":81061,"source":{"system":"sec-edgar","filing":"0001055726-20-000007","document":"wf-form4_158378499078811.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000007/wf-form4_158378499078811.xml","form_type":"4"}},{"id":3221028,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-03-09T20:16:49.000Z","date":"2020-03-08","kind":"exercise","acquired":true,"shares":19900,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 59,700 restricted stock units is as follows: 19,900 shares vested on March 8, 2020; 19,900 shares will vest on March 8, 2021; 19,900 shares will vest on March 8, 2022.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":87943,"source":{"system":"sec-edgar","filing":"0001055726-20-000007","document":"wf-form4_158378499078811.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000007/wf-form4_158378499078811.xml","form_type":"4"}},{"id":3221027,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-03-09T20:16:49.000Z","date":"2020-03-05","kind":"tax_withholding","acquired":false,"shares":9857,"price":9.8,"value":96598.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein."}],"balance_after":68043,"source":{"system":"sec-edgar","filing":"0001055726-20-000007","document":"wf-form4_158378499078811.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000007/wf-form4_158378499078811.xml","form_type":"4"}},{"id":3221026,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-03-09T20:16:49.000Z","date":"2020-03-05","kind":"exercise","acquired":true,"shares":27567,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 82,700 restricted stock units is as follows: 27,567 shares vested on March 5, 2019; 27,567 shares vested on March 5, 2020; 27,566 shares will vest on March 5, 2021.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":77900,"source":{"system":"sec-edgar","filing":"0001055726-20-000007","document":"wf-form4_158378499078811.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000007/wf-form4_158378499078811.xml","form_type":"4"}},{"id":3423655,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-09-04T13:57:59.000Z","date":"2019-08-30","kind":"purchase","acquired":true,"shares":4500,"price":2.22,"value":9990.0,"ownership":{"direct":true},"balance_after":50333,"source":{"system":"sec-edgar","filing":"0001055726-19-000056","document":"wf-form4_156760546440560.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572619000056/wf-form4_156760546440560.xml","form_type":"4"}},{"id":3500981,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-06-05T21:19:47.000Z","date":"2019-06-05","kind":"purchase","acquired":true,"shares":20000,"price":2.5,"value":50000.0,"ownership":{"direct":true},"balance_after":45833,"source":{"system":"sec-edgar","filing":"0001055726-19-000047","document":"wf-form4_155976957270687.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572619000047/wf-form4_155976957270687.xml","form_type":"4"}},{"id":3599994,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Unit","published_at":"2019-03-12T23:20:24.000Z","date":"2019-03-08","kind":"grant","acquired":true,"shares":59700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 59,700 restricted stock units is as follows: 19,900 shares will vest on March 8, 2020; 19,900 shares will vest on March 8, 2021; 19,900 shares will vest on March 10, 2022.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 59,700 restricted stock units is as follows: 19,900 shares will vest on March 8, 2020; 19,900 shares will vest on March 8, 2021; 19,900 shares will vest on March 10, 2022.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 59,700 restricted stock units is as follows: 19,900 shares will vest on March 8, 2020; 19,900 shares will vest on March 8, 2021; 19,900 shares will vest on March 10, 2022.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":59700,"derivative":{"expiration_date":"2029-03-08","underlying":"Common Stock","underlying_shares":59700},"source":{"system":"sec-edgar","filing":"0001055726-19-000018","document":"wf-form4_155243280950585.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572619000018/wf-form4_155243280950585.xml","form_type":"4"}},{"id":3599993,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock Option","published_at":"2019-03-12T23:20:24.000Z","date":"2019-03-08","kind":"grant","acquired":true,"shares":93200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The vesting schedule for the 93,200 options is as follows: 23,300 shares vested on March 8, 2019; 23,300 shares will vest on March 8, 2020; 23,300 shares will vest on March 8, 2021; 23,300 shares will vest on March 8, 2022."}],"balance_after":93200,"derivative":{"exercise_price":3.34,"exercise_date":"2019-03-08","expiration_date":"2029-03-08","underlying":"Common Stock","underlying_shares":93200},"source":{"system":"sec-edgar","filing":"0001055726-19-000018","document":"wf-form4_155243280950585.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572619000018/wf-form4_155243280950585.xml","form_type":"4"}},{"id":3599992,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Unit","published_at":"2019-03-12T23:20:24.000Z","date":"2019-03-10","kind":"exercise","acquired":false,"shares":2812,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 5,624 restricted stock units is as follows: 2,812 shares vested on March 10, 2019; 2,812 shares will vest on March 10, 2020. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 5,624 restricted stock units is as follows: 2,812 shares vested on March 10, 2019; 2,812 shares will vest on March 10, 2020. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 5,624 restricted stock units is as follows: 2,812 shares vested on March 10, 2019; 2,812 shares will vest on March 10, 2020. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 5,624 restricted stock units is as follows: 2,812 shares vested on March 10, 2019; 2,812 shares will vest on March 10, 2020. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":2812,"derivative":{"expiration_date":"2027-03-10","underlying":"Common Stock","underlying_shares":2812},"source":{"system":"sec-edgar","filing":"0001055726-19-000018","document":"wf-form4_155243280950585.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572619000018/wf-form4_155243280950585.xml","form_type":"4"}},{"id":3599991,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Unit","published_at":"2019-03-12T23:20:24.000Z","date":"2019-03-09","kind":"exercise","acquired":false,"shares":2666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The 2,666 restricted stock units vested on March 9, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The 2,666 restricted stock units vested on March 9, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The 2,666 restricted stock units vested on March 9, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The 2,666 restricted stock units vested on March 9, 2019."}],"balance_after":0,"derivative":{"expiration_date":"2029-03-08","underlying":"Common Stock","underlying_shares":2666},"source":{"system":"sec-edgar","filing":"0001055726-19-000018","document":"wf-form4_155243280950585.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572619000018/wf-form4_155243280950585.xml","form_type":"4"}},{"id":3599990,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-03-12T23:20:24.000Z","date":"2019-03-10","kind":"tax_withholding","acquired":false,"shares":948,"price":3.34,"value":3166.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (3) herein."}],"balance_after":25833,"source":{"system":"sec-edgar","filing":"0001055726-19-000018","document":"wf-form4_155243280950585.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572619000018/wf-form4_155243280950585.xml","form_type":"4"}},{"id":3599989,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-03-12T23:20:24.000Z","date":"2019-03-10","kind":"exercise","acquired":true,"shares":2812,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 5,624 restricted stock units is as follows: 2,812 shares vested on March 10, 2019; 2,812 shares will vest on March 10, 2020. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":26781,"source":{"system":"sec-edgar","filing":"0001055726-19-000018","document":"wf-form4_155243280950585.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572619000018/wf-form4_155243280950585.xml","form_type":"4"}},{"id":3599988,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-03-12T23:20:24.000Z","date":"2019-03-09","kind":"tax_withholding","acquired":false,"shares":898,"price":3.34,"value":2999.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein."}],"balance_after":23969,"source":{"system":"sec-edgar","filing":"0001055726-19-000018","document":"wf-form4_155243280950585.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572619000018/wf-form4_155243280950585.xml","form_type":"4"}}],"next_cursor":"2019-03-12T23:20:24.000000Z,3599988"}